- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Specific calpain inhibition protects kidney against inflammaging ; volume:7 ; number:1 ; day:14 ; month:8 ; year:2017 ; pages:1-16 ; date:12.2017
Scientific reports ; 7, Heft 1 (14.8.2017), 1-16, 12.2017
- Creator
-
Hanouna, Guillaume
Mesnard, Laurent
Vandermeersch, Sophie
Perez, Joëlle
Placier, Sandrine
Haymann, Jean-Philippe
Campagne, Fabien
Moroch, Julien
Bataille, Aurélien
Baud, Laurent
Letavernier, Emmanuel
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-017-07922-1
- URN
-
urn:nbn:de:101:1-2019102014210173778730
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hanouna, Guillaume
- Mesnard, Laurent
- Vandermeersch, Sophie
- Perez, Joëlle
- Placier, Sandrine
- Haymann, Jean-Philippe
- Campagne, Fabien
- Moroch, Julien
- Bataille, Aurélien
- Baud, Laurent
- Letavernier, Emmanuel
- SpringerLink (Online service)
Other Objects (12)
Calpain inhibition protects against UVB-induced degradation of dermal-epidermal junction-associated proteins
Glucosylceramide synthase inhibition protects against cardiac hypertrophy in chronic kidney disease
Inhibition of ACSL4 ameliorates tubular ferroptotic cell death and protects against fibrotic kidney disease
Nicotinamide protects against diabetic kidney disease through regulation of Sirt1
Verteporfin protects against Th17 cell‐mediated EAE independently of YAP inhibition
Verteporfin protects against Th17 cell‐mediated EAE independently of YAP inhibition
Inhibition of sphingolipid metabolism in osteosarcoma protects against CD151-mediated tumorigenicity
Knockout of interleukin-17A protects against sepsis-associated acute kidney injury
Targeting enhancer of zeste homolog 2 protects against acute kidney injury
Inhibition of insulin/IGF ‐1 receptor signaling protects from mitochondria‐mediated kidney failure
FTH1 protects against osteoarthritis by MAPK pathway inhibition of extracellular matrix degradation
Rapamycin protects kidney against ischemia reperfusion injury through recruitment of NKT cells
Calpain inhibition protects against UVB-induced degradation of dermal-epidermal junction-associated proteins
Glucosylceramide synthase inhibition protects against cardiac hypertrophy in chronic kidney disease
Inhibition of ACSL4 ameliorates tubular ferroptotic cell death and protects against fibrotic kidney disease
Nicotinamide protects against diabetic kidney disease through regulation of Sirt1
Verteporfin protects against Th17 cell‐mediated EAE independently of YAP inhibition
Verteporfin protects against Th17 cell‐mediated EAE independently of YAP inhibition
Inhibition of sphingolipid metabolism in osteosarcoma protects against CD151-mediated tumorigenicity
Knockout of interleukin-17A protects against sepsis-associated acute kidney injury
Targeting enhancer of zeste homolog 2 protects against acute kidney injury
Inhibition of insulin/IGF ‐1 receptor signaling protects from mitochondria‐mediated kidney failure
FTH1 protects against osteoarthritis by MAPK pathway inhibition of extracellular matrix degradation
Rapamycin protects kidney against ischemia reperfusion injury through recruitment of NKT cells
Calpain inhibition protects against UVB-induced degradation of dermal-epidermal junction-associated proteins
Glucosylceramide synthase inhibition protects against cardiac hypertrophy in chronic kidney disease
Inhibition of ACSL4 ameliorates tubular ferroptotic cell death and protects against fibrotic kidney disease
Nicotinamide protects against diabetic kidney disease through regulation of Sirt1
Verteporfin protects against Th17 cell‐mediated EAE independently of YAP inhibition
Verteporfin protects against Th17 cell‐mediated EAE independently of YAP inhibition
Inhibition of sphingolipid metabolism in osteosarcoma protects against CD151-mediated tumorigenicity
Knockout of interleukin-17A protects against sepsis-associated acute kidney injury
Targeting enhancer of zeste homolog 2 protects against acute kidney injury
Inhibition of insulin/IGF ‐1 receptor signaling protects from mitochondria‐mediated kidney failure
FTH1 protects against osteoarthritis by MAPK pathway inhibition of extracellular matrix degradation